SEVERE EVENING DYSKINESIAS IN ADVANCED PARKINSONS-DISEASE - CLINICAL DESCRIPTION, RELATION TO PLASMA LEVODOPA, AND TREATMENT

被引:19
作者
ZIMMERMAN, TR
SAGE, JI
LANG, AE
MARK, MH
机构
[1] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT NEUROL,NEW BRUNSWICK,NJ 08903
[2] UNIV TORONTO,TORONTO HOSP,DIV NEUROL,TORONTO,ON,CANADA
[3] UNIV TORONTO,TORONTO HOSP,PLAYFAIR NEUROSCI UNIT,TORONTO,ON,CANADA
关键词
PARKINSONS DISEASE; EVENING; DYSKINESIAS; LOW DOPA DYSKINESIAS;
D O I
10.1002/mds.870090208
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report four patients with Parkinson's disease who had an unusual pattern of severe chorea and dystonia in the evenings only. The temporal pattern of abnormal movements and simultaneous monitoring of plasma levodopa and clinical state were consistent with dyskinesias associated with subtherapeutic (low dopa dyskinesias) rather than peak concentrations of levodopa (high dopa dyskinesias). In two patients, addition of a direct-acting dopamine receptor agonist was helpful in ameliorating this complication of anitparkinson therapy.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 12 条
[1]  
[Anonymous], 1987, RECENT DEV PARKINSON
[2]   L-DOPA PHARMACOKINETICS IN PLASMA AND CISTERNAL AND LUMBAR CEREBROSPINAL-FLUID OF MONKEYS [J].
HAMMERSTAD, JP ;
WOODWARD, WR ;
GLIESSMAN, P ;
BOUCHER, B ;
NUTT, JG .
ANNALS OF NEUROLOGY, 1990, 27 (05) :495-499
[3]  
KOLLER WC, 1980, NEUROPHARMACOLOGY, V18, P831
[4]   DUODENAL DELIVERY OF LEVODOPA FOR ON-OFF FLUCTUATIONS IN PARKINSONISM - PRELIMINARY-OBSERVATIONS [J].
KURLAN, R ;
RUBIN, AJ ;
MILLER, C ;
RIVERACALIMLIM, L ;
CLARKE, A ;
SHOULSON, I .
ANNALS OF NEUROLOGY, 1986, 20 (02) :262-265
[5]   PERGOLIDE, A POTENT LONG-ACTING DOPAMINE-RECEPTOR AGONIST [J].
LEMBERGER, L ;
CRABTREE, R ;
CALLAGHAN, JT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :642-651
[6]  
MARK MH, 1989, ANN CLIN LAB SCI, V19, P101
[7]   COMPLEX DYSTONIA OF PARKINSONS-DISEASE - CLINICAL-FEATURES AND RELATION TO PLASMA LEVODOPA PROFILE [J].
MCHALE, DM ;
SAGE, JI ;
SONSALLA, PK ;
VITAGLIANO, D .
CLINICAL NEUROPHARMACOLOGY, 1990, 13 (02) :164-170
[8]  
MUENTER MD, 1977, MAYO CLIN PROC, V52, P163
[9]  
NUTT JG, 1990, NEUROLOGY, V40, P340
[10]  
RODNITZKY RL, 1992, NEUROLOGY, V42, P44